Meeder Advisory Services’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$274K	Sell	1,091 -239	-18%	-$59.5K	0.01%	549
2025 Q4	$366K	Sell	1,330 -458	-26%	-$125K	0.02%	462
2025 Q3	$469K	Buy	1,788 +242	+16%	+$58.8K	0.02%	403
2025 Q2	$338K	Sell	1,546 -505	-25%	-$108K	0.02%	461
2025 Q1	$459K	Buy	2,051 +400	+24%	+$110K	0.03%	372
2024 Q4	$541K	Buy	1,651 +280	+20%	+$88.1K	0.03%	334
2024 Q3	$412K	Sell	1,371 -53	-4%	-$16.2K	0.03%	382
2024 Q2	$469K	Buy	1,424 +270	+23%	+$95.4K	0.03%	326
2024 Q1	$457K	Buy	1,154 +7	+0.6%	+$2.59K	0.05%	291
2023 Q4	$404K	Sell	1,147 -24	-2%	-$8.49K	0.05%	295
2023 Q3	$439K	Sell	1,171 -274	-19%	-$106K	0.06%	283
2023 Q2	$553K	Buy	1,445 +108	+8%	+$38.6K	0.06%	267
2023 Q1	$463K	Buy	+1,337	New	+$391K	0.05%	290